Alan DelaRosa, MD (@alan_delarosamd) 's Twitter Profile
Alan DelaRosa, MD

@alan_delarosamd

IM Resident @TTUHSC El Paso| Ex-post doc GI Research fellow @MayoClinic | Member of Council on Clinical Cardiology (CLCD) @American_Heart; Media Ambassador 🇲🇽

ID: 1443974076687687719

calendar_today01-10-2021 16:20:28

70 Tweet

266 Followers

321 Following

AHA Science (@ahascience) 's Twitter Profile Photo

🧵/ Late breaking science results from #AHA23 will be posted to this thread at the time of presentation: SELECT MINT ORBITA-2 CRHCP Dementia POP-HT KARDIA-1 CARDIA-SSBP ARTESIA VERVE-101 ESPRIT SPEC-AI Nigeria SPEECH ⬇️ (bookmark this post)

Alan DelaRosa, MD (@alan_delarosamd) 's Twitter Profile Photo

Latest ground breaking news presented at #AHA23 American Heart Association ⭐️SELECT: Semaglutide reduced the risk of MACE by 20% in >27 BMI w/o diabetes ⭐️MINT: In pts w/ MI no difference in liberal vs restrictive blood transfusion ⭐️ORBITA-2: PCI outperformed placebo px for ppl with

Lizeth Cifuentes (@lizcifuentesmd) 's Twitter Profile Photo

"🔍 Exploring the synergy of Very Low-Calorie Diets and Anti-Obesity Medications! 🏋️‍♂️ Our study reveals promising results—significant weight loss and lower regain. 📊 Check out our findings for effective long-term weight management! onlinelibrary.wiley.com/doi/10.1002/os…

"🔍 Exploring the synergy of Very Low-Calorie Diets and Anti-Obesity Medications! 🏋️‍♂️ Our study reveals promising results—significant weight loss and lower regain. 📊 Check out our findings for effective long-term weight management! onlinelibrary.wiley.com/doi/10.1002/os…
JACC Journals (@jaccjournals) 's Twitter Profile Photo

New #JACCHF state-of-the-art review provides a comprehensive approach to the use of invasive hemodynamic assessments in patients supported with LVADs. bit.ly/3O36yge #LVAD #HeartFailure Filio Billia

New #JACCHF state-of-the-art review provides a comprehensive approach to the use of invasive hemodynamic assessments in patients supported with LVADs. bit.ly/3O36yge

#LVAD #HeartFailure <a href="/FilioBillia/">Filio Billia</a>
Lizeth Cifuentes (@lizcifuentesmd) 's Twitter Profile Photo

🔍 Just published our latest study: Weight loss and cardiovascular outcomes of 12-month semaglutide use. 🌟 Dive into the impact of semaglutide on obesity, metabolism, and heart health! #Semaglutide #ObesityResearch Wissam Ghusn Andres Acosta Diego Anazco, MD pubmed.ncbi.nlm.nih.gov/38302591/

Lizeth Cifuentes (@lizcifuentesmd) 's Twitter Profile Photo

🌟 Exciting findings in our latest article on weight loss outcomes with semaglutide! Kudos to Wissam Ghusn and Sima Fansa for their outstanding work. Check out the comparison between AOM-naïve and non-AOM-naïve patients in achieving weight loss goals. #WeightLoss #Semaglutide 📊

Digestive Disease Week (@ddwmeeting) 's Twitter Profile Photo

#DDW2024 researcher Andres Acosta found that a machine-learning genetic algorithm — the “hungry gut” phenotype test — can predict which patients will do best on semaglutide weight-loss drugs American Gastroenterological Association (AGA)

#DDW2024 researcher <a href="/dr_aac/">Andres Acosta</a> found that a machine-learning genetic algorithm — the “hungry gut” phenotype test — can predict which patients will do best on semaglutide weight-loss drugs  <a href="/AmerGastroAssn/">American Gastroenterological Association (AGA)</a>